ACE and cardiovascular disorder: If ERT is started, angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARB) should be started or continued according to the treatment guidelines for chronic kidney disease (KDIGO) [38] and cardiovascular disease (ESC) [39].